Medtronic Vascular
Clinical trials sponsored by Medtronic Vascular, explained in plain language.
-
Device zaps kidney nerves to tame stubborn high blood pressure
Disease control OngoingThis study is testing a medical device procedure called renal denervation for people whose high blood pressure remains uncontrolled despite medications. The procedure uses a catheter to deliver energy to nerves around the kidney arteries, aiming to lower blood pressure long-term.…
Phase: NA • Sponsor: Medtronic Vascular • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New heart stent goes Head-to-Head with established model in major chinese trial
Disease control OngoingThis study compares two similar drug-coated stents used to prop open blocked heart arteries. It will enroll 550 patients in China who need this procedure to see if the newer Resolute Onyx stent performs as well as the established Resolute Integrity stent. Researchers will track p…
Phase: NA • Sponsor: Medtronic Vascular • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
New heart stent put to the test in major chinese trial
Disease control OngoingThis study is testing the safety and effectiveness of a specific drug-coated heart stent (the Medtronic Resolute Onyx) in Chinese patients with blocked coronary arteries. About 591 participants who are eligible for a standard artery-opening procedure (angioplasty) will receive th…
Phase: NA • Sponsor: Medtronic Vascular • Aim: Disease control
Last updated Mar 10, 2026 12:53 UTC